PCBP1 regulates alternative splicing of AARS2 in congenital cardiomyopathy

Related articles

eBlogs

09
03
26

Basecalling: A method to characterize multiple critical quality attributes 

Basecalling directly determines what nucleotide bases are in an RNA sequence, revealing actionable characterization insights.

read more

Press Releases

09
01
26

Eclipsebio expands its RNA characterization capabilities with multi-attribute nanopore-based sequencing assay eSTRAND RNA QC™ 

eSTRAND RNA QC uses direct RNA sequencing to provide multiple critical quality attributes in a single run without requiring reverse transcription or translation.

read more
6th Annual mRNA-Based Therapeutics Summit

eBlogs

08
10
26

From promise to proof: Reflections on the 6th mRNA-Based Therapeutics Summit

This year's mRNA-Based Therapeutics Summit proved that RNA is a platform, but drug developers must close analytical gaps to see how their constructs work.

read more

Press Releases

08
04
26

Wacker Biotech and Eclipsebio Announce Strategic Collaboration to Advance RNA Medicine Development and Production

The collaboration will combine Wacker Biotech's large-scale, GMP-compliant manufacturing with Eclipsebio's AI-driven RNA design and sequencing-based characterization for best-in-class end-to-end RNA therapeutic development support.

read more